It is a pharma private limited company based in Greater Noida, Uttar Pradesh, India, established in 2017.
2017 | Greater Noida, Uttar Pradesh, India | ActiveAclima Therapeutics Derive Private Limited, a active private limited company, was established on 04 October 2017 in Greater Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909UP2017PTC097522. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ashish Agrawal (Director), Parul Agrawal (Director), Ritie Aggrawal (Director). Past directors included Harish Agarwal Chandra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at L-701, Plumeria Garden Estate, Near Achhar Village Omicron-3, Kasana, Greater Noida, Uttar Pradesh, 201310.
U51909UP2017PTC097522
097522
04 October 2017
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Aclima Therapeutics Derive Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Agrawal | Director | 02 Dec 2020 | Current |
| Parul Agrawal | Director | 04 Oct 2017 | Current |
| Ritie Aggrawal | Director | 29 May 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aclima Therapeutics Derive Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.27% increase. The company also saw a slight improvement in profitability, with a 6.8% increase in profit. The company's net worth Soared by an impressive increase of 34.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aclima Therapeutics Derive had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aclima Therapeutics Derive, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aclima Therapeutics Derive, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aclima Therapeutics Derive's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aclima Therapeutics Derive Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Aclima Therapeutics Derive Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
Ashish Agrawal was appointed as a Director was appointed as a Director on 02 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Ritie Aggrawal was appointed as a Director was appointed as a Director on 29 May 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
Parul Agrawal was appointed as a Director was appointed as a Director on 04 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Progress on Aclima Therapeutics Derive Private Limited was registered on 04 Oct 2017 with Roc Kanpur & aged 8 years 1 month as per MCA records. was documented.
The CIN of Aclima Therapeutics Derive Private Limited is U51909UP2017PTC097522.
Aclima Therapeutics Derive Private Limited is headquartered at L-701, Plumeria Garden Estate, Near Achhar Village Omicron-3, Kasana, Greater Noida, Uttar Pradesh, 201310.
Aclima Therapeutics Derive Private Limited was incorporated on 04 October 2017.
The current directors of Aclima Therapeutics Derive Private Limited are
The primary industry of Aclima Therapeutics Derive Private Limited is Trade.
Aclima Therapeutics Derive Private Limited is unlisted.
The authorized capital of Aclima Therapeutics Derive Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aclima Therapeutics Derive Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX